Lomustine
Drug timelines are a Plus or Pro feature.
28 regulatory and trial events tracked for Lomustine, covering 2007-05-30 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma [Phase 2]